 | Up a level |
Fiaschetti, Giulio; Schroeder, Christina; Castelletti, Deborah; Arcaro, Alexandre; Westermann, Frank; Baumgartner, Martin; Shalaby, Tarek; Grotzer, Michael A (2014). NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta neuropathologica communications, 2, p. 39. BioMed Central 10.1186/2051-5960-2-39
Castelletti, Deborah; Fiaschetti, Giulio; Di Dato, Valeria; Ziegler, Urs; Kumps, Candy; De Preter, Katleen; Zollo, Massimo; Speleman, Frank; Shalaby, Tarek; De Martino, Daniela; Berg, Thorsten; Eggert, Angelika; Arcaro, Alexandre; Grotzer, Michael A (2010). The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors. Molecular cancer therapeutics, 9(12), pp. 3145-57. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1535-7163.MCT-10-0539
Shalaby, Tarek; von Bueren, André O; Hürlimann, Marie-Louise; Fiaschetti, Giulio; Castelletti, Deborah; Masayuki, Tera; Nagasawa, Kazuo; Arcaro, Alexandre; Jelesarov, Ilian; Shin-ya, Kazuo; Grotzer, Michael (2010). Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Molecular cancer therapeutics, 9(1), pp. 167-79. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1535-7163.MCT-09-0586
Grotzer, Michael A; Castelletti, Deborah; Fiaschetti, Giulio; Shalaby, Tarek; Arcaro, Alexandre (2009). Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Current cancer drug targets, 9(2), pp. 176-88. Hilversum: Bentham Science Publishers 10.2174/156800909787580962
